TERAPI1.: Protection of Intellectual Property rights of new therapeutic agents against amyloid transthyretin diseases (Q2866969): Difference between revisions
Jump to navigation
Jump to search
(Removed claim: co-financing rate (P837): 50.0 percentage) |
(Changed an Item: Import item from Portugal) |
||||||||||
| Property / budget | Property / budget | ||||||||||
| 48,768.66 Euro
| ||||||||||
| Property / EU contribution | Property / EU contribution | ||||||||||
| 24,384.33 Euro
| ||||||||||
| Property / priority axis | |||||||||||
| Property / priority axis: Research, Development and Innovation (DIIAS) / rank | |||||||||||
Normal rank | |||||||||||
| Property / co-financing rate | |||||||||||
50.0 percent
| |||||||||||
| Property / co-financing rate: 50.0 percent / rank | |||||||||||
Normal rank | |||||||||||
Revision as of 10:34, 7 November 2022
Project Q2866969 in Portugal
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | TERAPI1.: Protection of Intellectual Property rights of new therapeutic agents against amyloid transthyretin diseases |
Project Q2866969 in Portugal |
Statements
24,384.33 Euro
0 references
48,768.66 Euro
0 references
50.0 percent
0 references
20 May 2017
0 references
19 May 2021
0 references
BSIM THERAPEUTICS, S.A.
0 references
Q2988326 (Deleted Item)
0 references
40°21'55.76"N, 8°39'29.95"W
0 references
Cantanhede
0 references
Identifiers
CENTRO-01-0247-FEDER-028007
0 references